Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore

21 Apr 2011

Abstract excerpt

OBJECTIVE: Carbapenem-resistant Acinetobacter baumannii (CR-AB) is an emerging cause of nosocomial infections worldwide. Combination therapy may be the only viable option until new antibiotics become available. The objective of this study is to identify potential antimicrobial combinations against CR-AB isolated from our local hospitals. METHODS: AB isolates from all public hospitals in Singapore were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotic Use and Resistance
Share to Nosocomial Infections in ICU

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21533030
DOI: 10.1371/journal.pone.0018485

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in SingaporePMID 21533030Read ↗

Carbapenems-resistant Pseudomonas aeruginosa bloodstream infection in Hematopoietic stem cell transplant patients: in vitro synergy and clinical outcomeSemantic proximity Read ↗

Comprehensive In Vitro Evaluation of Antimicrobial Combinations Against Extensively Drug- Resistant Acinetobacter baumannii: Planktonic and Biofilm PerspectivesSemantic proximity Read ↗

Molecular typing of imipenem-resistant Acinetobacter baumannii-calcoaceticus complex in a Singapore hospital where carbapenem resistance is endemic.Semantic proximity Read ↗

Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex species: what can we expect in the future?Semantic proximity Read ↗

Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.Semantic proximity Read ↗

Challenges in Identifying New Antimicrobial Agents Effective for Treating Infections with Acinetobacter baumannii and Pseudomonas aeruginosaSemantic proximity Read ↗

Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance MechanismsSemantic proximity Read ↗

Reduction in chlorhexidine efficacy against multi-drug-resistant Acinetobacter baumannii international clone II.Semantic proximity Read ↗

In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam.Semantic proximity Read ↗

Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii.Semantic proximity Read ↗

Novel Approach To Optimize Synergistic Carbapenem-Aminoglycoside Combinations against Carbapenem-Resistant Acinetobacter baumanniiSemantic proximity Read ↗

In vitro activity of antibiotic combinations against multidrug-resistant strains of Acinetobacter baumannii and the effects of their antibiotic resistance determinants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.